David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk. David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech. David Stermanon

Analyst Articles

You and I drive 70% of economic activity in this country. We are consumers. If we lose our jobs or our confidence in the economy, we stop spending. Businesses make less money and pull back on production. They lay off workers, who spend less money, and the vicious cycle continues. Some companies survive recessions and prosper in good economies because they make things we can’t do without, like toilet paper, soap and food. Other companies serve folks who have extra money to spend on special things, like hotels, jewelry and air… Read More

You and I drive 70% of economic activity in this country. We are consumers. If we lose our jobs or our confidence in the economy, we stop spending. Businesses make less money and pull back on production. They lay off workers, who spend less money, and the vicious cycle continues. Some companies survive recessions and prosper in good economies because they make things we can’t do without, like toilet paper, soap and food. Other companies serve folks who have extra money to spend on special things, like hotels, jewelry and air travel. [Read: 3 Reasons Why this Small Cap Could Return +200%] There is, however, a further class of discretionary expense called the luxury item. If a company sells luxury items, then chances are it has been devastated in this recession and its stock has been destroyed. #-ad_banner-#But if that company can survive the recession, bargain hunters may find a multi-bagger investment that others totally miss. I found one such company that a lot of investors had written off, but has since rocketed +400% off its lows. But even… Read More

Over the next few quarters, look for Google (Nasdaq: GOOG) to keep up the pressure on Apple (Nasdaq: AAPL) as it enters the music download business, strengthens the Android software platform’s capabilities, and likely rolls out a few new technologies and services we have not yet heard about. [Read: Apple’s… Read More

As the market grinds down toward the end of the summer, we’re seeing the typical seasonal malaise when a number of good companies quietly drift down to 52-week lows. And the selling may not be over. The S&P 500 has historically been the weakest in September, dropping an average of -1.3%. The good news: stocks really build a head of steam after that. The S&P 500 typically rises +0.7% in October, followed by average monthly gains of +1.5%, +1.9% and +2.1% in each of the next three months. Savvy investors always keep some cash on hand for… Read More

As the market grinds down toward the end of the summer, we’re seeing the typical seasonal malaise when a number of good companies quietly drift down to 52-week lows. And the selling may not be over. The S&P 500 has historically been the weakest in September, dropping an average of -1.3%. The good news: stocks really build a head of steam after that. The S&P 500 typically rises +0.7% in October, followed by average monthly gains of +1.5%, +1.9% and +2.1% in each of the next three months. Savvy investors always keep some cash on hand for these summer doldrums, as it can be a fertile time to start researching unloved stocks that should find new appreciation as summer turns to fall. Here are four names hitting new 52-week lows on Friday that should be quite appealing for long-term investors. MedcoHealth Solutions (NYSE: MHS) Earlier this summer, we saw a considerable dust-up between CVS (NYSE: CVS) and Walgreen (NYSE: WAG) as those two firms fought over a pharmacy benefits manager (PBM) contract. As we looked into the PBM sector in June, we saw still-considerable growth prospects,… Read More

One of the prevailing theories about the economy is that it is consumer-driven, a postulation I happen to agree with, given that consumer spending accounts for 70% of all economic activity. Part of the reason this recession began is because credit… Read More